tiprankstipranks
Advertisement
Advertisement

VOR Stock Latest News

Vor Biopharma shareholders back directors and governance measures
Company AnnouncementsVor Biopharma shareholders back directors and governance measures
8m ago
8K
VOR
Vor Bio gains boost from telitacicept IgA nephropathy approval
PremiumCompany Announcements
Vor Bio gains boost from telitacicept IgA nephropathy approval
4d ago
8K
VOR
Vor Bio announces China NMPA approval for telitacicept
PremiumThe Fly
Vor Bio announces China NMPA approval for telitacicept
4d ago
VOR
Vor Biopharma’s Phase 3 Sjögren’s Trial Puts Telitacicept on Investors’ Radar
PremiumCompany Announcements
Vor Biopharma’s Phase 3 Sjögren’s Trial Puts Telitacicept on Investors’ Radar
8d ago
VOR
Vor Biopharma: Buy Rating Reiterated on Strong Telitacicept Validation and Autoimmune Growth Runway; $31 Price Target Unchanged
PremiumRatings
Vor Biopharma: Buy Rating Reiterated on Strong Telitacicept Validation and Autoimmune Growth Runway; $31 Price Target Unchanged
25d ago
VOR
Vor Bio price target raised to $18 from $15 at Wedbush
PremiumThe FlyVor Bio price target raised to $18 from $15 at Wedbush
29d ago
VOR
Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
Premium
Company Announcements
Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
1M ago
VOR
Vor Bio files to sell 5.34M shares of common stock for holders
Premium
The Fly
Vor Bio files to sell 5.34M shares of common stock for holders
2M ago
VOR
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
PremiumWeekend Updates
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
2M ago
HDB
STT
Bj’s, Atlas, Academy, Vor, Global-e: Insider Shakeup
PremiumWeekend Updates
Bj’s, Atlas, Academy, Vor, Global-e: Insider Shakeup
2M ago
BJ
ASO
Vor Bio price target lowered to $31 from $32 at H.C. Wainwright
PremiumThe Fly
Vor Bio price target lowered to $31 from $32 at H.C. Wainwright
2M ago
VOR
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
PremiumWeekend Updates
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
2M ago
SG
VOR
Vor Bio price target raised to $15 from $9 at Wedbush
PremiumThe FlyVor Bio price target raised to $15 from $9 at Wedbush
2M ago
VOR
Vor Bio price target lowered to $40 from $55 at Stifel
Premium
The Fly
Vor Bio price target lowered to $40 from $55 at Stifel
2M ago
VOR
Vor Bio price target lowered to $40 from $55 at Stifel
Premium
The Fly
Vor Bio price target lowered to $40 from $55 at Stifel
2M ago
VOR
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
PremiumRatings
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
2M ago
VOR
Vor Bio doses first patient in UPSTREAM SjD study
PremiumThe Fly
Vor Bio doses first patient in UPSTREAM SjD study
2M ago
VOR
Vor Bio initiated with a Buy at Jefferies
PremiumThe Fly
Vor Bio initiated with a Buy at Jefferies
2M ago
VOR
Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
PremiumRatings
Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
2M ago
VOR
Vor Biopharma Announces $75 Million Private Placement Financing
PremiumCompany AnnouncementsVor Biopharma Announces $75 Million Private Placement Financing
3M ago
8K
VOR
Vor Bio to sell 5.338M shares at $14.05 in private placement
Premium
The Fly
Vor Bio to sell 5.338M shares at $14.05 in private placement
3M ago
VOR
Vor Bio initiated with an Overweight at Wells Fargo
Premium
The Fly
Vor Bio initiated with an Overweight at Wells Fargo
3M ago
VOR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >